Effect of essential oils as penetration enhancers on percutaneous penetration of furosemide through human cadaver skin

Acta Pharmaceutica Sciencia

Volumn 52, Issue 2, 2010, Pages 159-168

  Setty, C Mallikarjuna ^a,b   Jawarkar, Yogesh ^c   Pathan, Inayat Bashir ^d  

^a Saraswathi College of Pharmaceutical Sciences   (India)

^b Sonai ^*  (India)

^c Blue Cross Pharmaceutical Ltd   (India)

^d MES's College of Pharmacy   (India)

Author keywords

Essential oils; Furosemide; Permeation study; Transdermal patches

Indexed keywords

EID: 77954238530     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Agyralides, G.G., Dallas, P.P. and Rekkas, D.M. (2004). Development and in vitro evaluation of furosemide transdermal formulation using experimental design techniques. Int. J. Pharm. 281: 35-43.
2. Arora, P. and Mukherjee, B. (2002). Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethyl ammonium salt. J. Pharm. Sci. 91: 2076-2089.
3. Barry, B.W. (2001). Is transdermal drug delivery research still important today? DDT. 6: 967-971.
4. Barry, B.W. and Williams, A.C. (1989). Human skin penetration enhancement: the synergy of propylene glycol with terpenes. Proc. Int. Symp. Control Rel. Bioact. Mater. 16: 33-34.
5. Barry, B.W. and Williams, A.C. (1993). Terpenes as skin penetration enhancers. In: Walters, K.A., Hadgraft, J. (Eds.), Pharmaceutical skin permeation enhancement. Marcel Dekker, New York. 95-111.
6. Cleary, G.W. (1984). Medical applications of controlled release. In: D. L. Langer (Ed.) Transdermal Controlled release systems, Boca Raton, FL: CRC Press. pp 203-251.
7. Cho, C.W., Choi, J.S. and Shin, S.C. (2005). Controlled release of furosemide from ethylene vinyl acetate matrix. Int. J. Pharm. 299: 127-133.
8. Cornwell, P.A., Barry, B.W., Bouwstra, J.A. and Gooris, G.S. (1996). Modes of action of terpenes penetration enhancers in human skin; diffraction and enhancer uptake studies. Int. J. Pharm. 127: 9-26.
9. Cornwell, P.A. and Barry, B.W. (1991). The effect of a series of homologous terpene alcohols on lipid structure of human stratum corneum as assessed by differential scaning calorimetry. In scott,R.C., Guy, R.H., Hadgraft, J. and Bodde, H.E. (Eds), Prediction of Percutaneous Penetration, IBC Technical Services, London. 2, pp 394-400.
10. Cornwell, P.A. and Barry, B.W. (1995). Effect of penetration enhancer treatment on the statistical distribution of human skin permeabilities. Int. J. Pharm. 117: 101-112.
11. Devi, V., Saisivam, S., Maria, G.R. and Deepti, P.U. (2003). Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev. Ind. Pharm. 29: 495-503.
12. Elfbaum, S.G. and Laden, K. (1968). The effect of dimethyl sulfoxide on percutaneous absorption: a mechanistic study. J. Cutaneous Pathol. 259-264.
13. Giebisch, G. (1985). The use of the diuretic agent as probe to investigate site and mechanisam of ion transport process. 35: 336-342.
14. Kobayashi, D., Matsuzawa, T., Sugibayashi, K., Morimoto, Y. and Kimura, M. (1994). Analysis of combined effect of 1-menthol and ethanol as skin permeation enhancers based on two-layer skin model. Pharm Res. 11: 96-103.
15. Kydonieus, A. F. (1987). Controlled release technologies. Boca Raton, FL: CRC Press.
16. Mukherjee, B., Mahapatra, S., Gupta, R., Patra, B., Tiwari, A. and Arora, P. A. (2005). Comparison of povidone-ethylcellilose and povidone-eidragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur. J. Pharm. Biopharm. 59: 475-483.
17. Mukherjee, B., Kanupriya, M.S., Das, S. and Patra, B. (2005). Sorbitan monolaurate 20 as a potential skin permeation enhancer in transdermal patches. J. Applied Res. 5: 96-108.
18. Mehidizadeh, A., Toliate, T., Rouini, M., Abashzadeh, S. and Dorkoosh, F. (2004). Design and in vitro evaluation of new drug in adhesive formulation of fentanyl transdermal patches. Acta Pharm. 54: 301-317.
19. Sintov, A.C., Krymberk, I., Gavrilov, V. and Gorodischer, R. (2003). Transdermal delivery of paracetamol for paediatric use: effect of vehicle formulation on the percutaneous penetration. J. Pharm. Pharamco. 55: 911-919.
20. Williams, A.C. and Barry, B.W. (1991). The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophillic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int. J. Pharm. 74: 157-168.
21. Yoneto, K., Ghanem, A.H., Higuchi, W.I., Peck, K.D. and Li, S.K. (1995). Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J. Pharm. Sci. 84: 312-317.
22. Yoneto, K., Li, S.K., Higuchi, W.I. and Shimabayashi, S. (1998). Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J. Pharm. Sci. 87: 209-214.